LOUISVILLE, Ky. (WHAS11) - - For the second time since June the Federal Drug Adminastration has approved a new prescription diet drug.
Qsymia was given to patients in clinical trials and they lost an average of 23 pounds.
But some consumer advocates are concerned about the drug's side effects which could include an increased heart rate, hyperventilation, fatigue and anorexia.
Concerns have also been raised about birth defects because an ingredient in the drug has been linked to cleft palates and lips.
The drug is recommended for patients with a body mass index over 27.
